Surmodics reported $94.11M in Current Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Abbott ABT:US $ 22627M 810M
Align Technology ALGN:US $ 2231.82M 116.27M
Anika Therapeutics ANIK:US $ 177.76M 4.29M
Arrowhead Research ARWR:US $ 525.96M 60.8M
Baxter International BAX:US $ 8004M 148M
Bioscrip BIOS:US $ 735.76M 71.03M
Cryolife CRY:US $ 238.05M 2.37M
Edap Tms EDAP:US $ 65.37M 21.82M
Edwards Lifesciences EW:US $ 3322.9M 253.7M
Genmark Diagnostics GNMK:US $ 172.96M 2.95M
Haemonetics HAE:US $ 684.37M 9.18M
Heron Therapeutics HRTX:US $ 366.83M 94.54M
Merit Medical Systems MMSI:US $ 449.78M 11.29M
Mesa Laboratories MLAB:US $ 315.31M 11.56M
Nektar Therapeutics NKTR:US $ 1056.15M 42.9M
Oxford Immunotec Global OXFD:US $ 188.37M 1.42M
Providence Service PRSC:US $ 557.02M 19.79M
Stryker SYK:US $ 9032M 53M
Surmodics SRDX:US $ 94.11M 1.07M
Trinity Biotech TRIB:US $ 81.46M 6.15M